What is the most likely cause of Minimal Change Disease (MCD), a type of Nephrotic Syndrome (NS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The most likely cause of Minimal Change Disease (MCD) is unknown, but it is believed to be immune-mediated, involving T-cell dysfunction that leads to the release of cytokines or other factors that damage podocytes in the glomeruli of the kidneys, as suggested by the most recent study in 2023 1. The exact etiology of MCD remains unclear, but it is considered an idiopathic condition in most cases.

  • MCD is characterized by intense proteinuria leading to edema and intravascular volume depletion, as described in a study published in 2017 2.
  • The disease is more common in children, but can occur at any age, and is highly responsive to corticosteroids, as reported in a review published in 2006 3.
  • The hallmark of MCD is the absence of visible structural changes in the glomeruli under light microscopy, with only foot process effacement visible on electron microscopy, which distinguishes it from other causes of nephrotic syndrome, as noted in a study published in 2017 2.
  • In some cases, MCD can be triggered by certain medications, infections, allergic reactions, or malignancies, particularly Hodgkin's lymphoma, as mentioned in the example answer.
  • Recent studies have explored the use of rituximab, a monoclonal antibody against CD20 B-lymphocytes, as a treatment option for MCD, with promising results, as reported in studies published in 2022 4 and 2011 5.
  • However, the most recent and highest quality study, published in 2023 1, suggests that the pathobiology of MCD remains poorly understood, and further research is needed to determine the exact cause of the disease.
  • The study published in 2023 1 found that T-cell receptor diversity did not differ between MCD active disease and remission states, and did not identify dominant clonotypes in MCD active disease, which suggests that the immune system may play a role in the development of MCD, but the exact mechanisms are still unclear.

References

Research

T-cell receptor diversity in minimal change disease in the NEPTUNE study.

Pediatric nephrology (Berlin, Germany), 2023

Research

Minimal Change Disease.

Clinical journal of the American Society of Nephrology : CJASN, 2017

Research

Minimal change disease: a review.

Southern medical journal, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.